1. Berberine Inhibits FOXM1 Dependent Transcriptional Regulation of POLE2 and Interferes With the Survival of Lung Adenocarcinoma
   Lulu Ni et al, 2022, Frontiers in Pharmacology CrossRef
2. Berberine and Cisplatin Exhibit Synergistic Anticancer Effects on Osteosarcoma MG-63 Cells by Inhibiting the MAPK Pathway
   Xianxian Gao et al, 2021, Molecules CrossRef
3. Molecular and cellular aspects of the impact of secondary metabolites from common barberry and hybrid goat’s rue on the HeLa cell line
   E. Yu. Zlatnik et al, 2023, Research and Practical Medicine Journal CrossRef
4. Berberine: An Important Emphasis on Its Anticancer Effects through Modulation of Various Cell Signaling Pathways
   Saleh A. Almatroodi et al, 2022, Molecules CrossRef
5. Berberine Hampers Influenza A Replication through Inhibition of MAPK/ERK Pathway
   Paweł Botwina et al, 2020, Viruses CrossRef
6. Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy
   Sajad Fakhri et al, 2022, Frontiers in Oncology CrossRef
7. Understanding Lung Carcinogenesis from a Morphostatic Perspective: Prevention and Therapeutic Potential of Phytochemicals for Targeting Cancer Stem Cells
   Win Sen Heng et al, 2021, International Journal of Molecular Sciences CrossRef
8. Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers
   Luying He et al, 2022, Frontiers in Pharmacology CrossRef
9. Effects of Berberine and Its Derivatives on Cancer: A Systems Pharmacology Review
   Chaohe Zhang et al, 2020, Frontiers in Pharmacology CrossRef
10. Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review
    Ruo-Gu Xiong et al, 2022, Molecules CrossRef
11. Apoptosis Induction, a Sharp Edge of Berberine to Exert Anti-Cancer Effects, Focus on Breast, Lung, and Liver Cancer
    Yi Zhu et al, 2022, Frontiers in Pharmacology CrossRef
12. Oxyepiberberine from the Active Site of Coptidis Rhizoma Inhibits Lung Adenocarcinoma by Regulating SRC-related Pathways in vivo
    Ying Zhang et al, 2024, Pharmacognosy Magazine CrossRef
13. A Natural Isoquinoline Alkaloid With Antitumor Activity: Studies of the Biological Activities of Berberine
    Da Liu et al, 2019, Frontiers in Pharmacology CrossRef
14. Natural Compounds as Versatile Potential Therapeutic Agents of Lung Cancer
    Rabia Akram et al, 2021, Medicinal Plants for Lung Diseases CrossRef
15. Berberine chloride suppresses non-small cell lung cancer by deregulating Sin3A/TOP2B pathway in vitro and in vivo
    Jian Chen et al, 2020, Cancer Chemotherapy and Pharmacology CrossRef
16. Anticancer Mechanisms of Berberine: A Good Choice for Glioblastoma Multiforme Therapy
    Bahram Bibak et al, 2022, Current Medicinal Chemistry CrossRef
17. Berberine regulates pulmonary inflammatory microenvironment and decreases collagen deposition in response to bleomycin‐induced pulmonary fibrosis in mice
    Zheng Yang et al, 2023, Basic & Clinical Pharmacology & Toxicology CrossRef
18. 9-O-Terpenyl-Substituted Berberrubine Derivatives Suppress Tumor Migration and Increase Anti-Human Non-Small-Cell Lung Cancer Activity
    Jia-Ming Chang et al, 2021, International Journal of Molecular Sciences CrossRef
19. The Molecular Mechanisms Involved in Suppressing Triple Negative Breast Cancer Using Natural Agents
    Saabira Banu Sahubar Sadik et al, 2022, Handbook of Research on Natural Products and Their Bioactive Compounds as Cancer Therapeutics CrossRef